These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721 [TBL] [Abstract][Full Text] [Related]
3. Community emergence of CTX-M type extended-spectrum beta-lactamases among urinary Escherichia coli from women. Ho PL; Poon WW; Loke SL; Leung MS; Chow KH; Wong RC; Yip KS; Lai EL; Tsang KW; J Antimicrob Chemother; 2007 Jul; 60(1):140-4. PubMed ID: 17496058 [TBL] [Abstract][Full Text] [Related]
4. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals. Peirano G; Costello M; Pitout JD Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869 [TBL] [Abstract][Full Text] [Related]
5. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin. Oteo J; Orden B; Bautista V; Cuevas O; Arroyo M; Martínez-Ruiz R; Pérez-Vázquez M; Alcaraz M; García-Cobos S; Campos J J Antimicrob Chemother; 2009 Oct; 64(4):712-7. PubMed ID: 19671590 [TBL] [Abstract][Full Text] [Related]
6. Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15. Yumuk Z; Afacan G; Nicolas-Chanoine MH; Sotto A; Lavigne JP J Antimicrob Chemother; 2008 Aug; 62(2):284-8. PubMed ID: 18453527 [TBL] [Abstract][Full Text] [Related]
7. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Azap OK; Arslan H; Serefhanoğlu K; Colakoğlu S; Erdoğan H; Timurkaynak F; Senger SS Clin Microbiol Infect; 2010 Feb; 16(2):147-51. PubMed ID: 19689464 [TBL] [Abstract][Full Text] [Related]
8. CTX-M type extended spectrum beta-lactamases in Escherichia coli isolates from community acquired upper urinary tract infections at a university in the European part of Turkey. Celik AD; Yulugkural Z; Kuloglu F; Eroglu C; Torol S; Vahaboğlu H; Akata F J Microbiol Immunol Infect; 2010 Apr; 43(2):163-7. PubMed ID: 20457435 [TBL] [Abstract][Full Text] [Related]
9. Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection. Rodríguez-Baño J; Alcalá J; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A J Antimicrob Chemother; 2009 Apr; 63(4):781-4. PubMed ID: 19223299 [TBL] [Abstract][Full Text] [Related]
10. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15. Blanco M; Alonso MP; Nicolas-Chanoine MH; Dahbi G; Mora A; Blanco JE; López C; Cortés P; Llagostera M; Leflon-Guibout V; Puentes B; Mamani R; Herrera A; Coira MA; García-Garrote F; Pita JM; Blanco J J Antimicrob Chemother; 2009 Jun; 63(6):1135-41. PubMed ID: 19351692 [TBL] [Abstract][Full Text] [Related]
11. Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams. Kariuki S; Revathi G; Corkill J; Kiiru J; Mwituria J; Mirza N; Hart CA J Infect Dev Ctries; 2007 Dec; 1(3):257-62. PubMed ID: 19734602 [TBL] [Abstract][Full Text] [Related]
12. Changing prevalence of Escherichia coli with CTX-M-type extended-spectrum beta-lactamases in outpatient urinary E. coli between 2003 and 2008. Qi C; Pilla V; Yu JH; Reed K Diagn Microbiol Infect Dis; 2010 May; 67(1):87-91. PubMed ID: 20227224 [TBL] [Abstract][Full Text] [Related]
13. CTX-M-producing Escherichia coli in a maternity ward: a likely community importation and evidence of mother-to-neonate transmission. Dubois V; De Barbeyrac B; Rogues AM; Arpin C; Coulange L; Andre C; M'zali F; Megraud F; Quentin C J Antimicrob Chemother; 2010 Jul; 65(7):1368-71. PubMed ID: 20466850 [TBL] [Abstract][Full Text] [Related]
14. CTX-M-15 extended-spectrum (beta)-lactamase from Nigerian Klebsiella pneumoniae. Soge OO; Queenan AM; Ojo KK; Adeniyi BA; Roberts MC J Antimicrob Chemother; 2006 Jan; 57(1):24-30. PubMed ID: 16319181 [TBL] [Abstract][Full Text] [Related]
15. [Identification and expression of blaCTX-M-14 and blaCTX-M-24]. Xiong ZZ; Zhu DM; Wang F; Zhang YY Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1454-9. PubMed ID: 15500745 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of rectal carriage of extended-spectrum beta-lactamase-producing Escherichia coli among elderly people in community settings in China. Tian SF; Chen BY; Chu YZ; Wang S Can J Microbiol; 2008 Sep; 54(9):781-5. PubMed ID: 18772941 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and types of extended-spectrum beta-lactamases among urinary Escherichia coli and Klebsiella spp. in New Zealand. Heffernan HM; Woodhouse RE; Pope CE; Blackmore TK Int J Antimicrob Agents; 2009 Dec; 34(6):544-9. PubMed ID: 19748232 [TBL] [Abstract][Full Text] [Related]
18. Integron-mediated ESBL resistance in rare serotypes of Escherichia coli causing infections in an elderly population of Israel. Sompolinsky D; Nitzan Y; Tetry S; Wolk M; Vulikh I; Kerrn MB; Sandvang D; Hershkovits G; Katcoff DJ J Antimicrob Chemother; 2005 Jan; 55(1):119-22. PubMed ID: 15574469 [TBL] [Abstract][Full Text] [Related]
19. CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia. Martinez P; Garzón D; Mattar S Braz J Infect Dis; 2012; 16(5):420-5. PubMed ID: 22964287 [TBL] [Abstract][Full Text] [Related]